EMAIL: [email protected]
PHONE: 720.907.1935

Lisa Bernard-Kuhn

Lisa is an award-winning business reporter specializing in finance and public companies in the cannabis industry for Marijuana Business Daily. Previously, she worked as an investigative reporter at WCPO-9, an affiliate of the ABC network. She has extensive business reporting experience, covering public companies, real estate and health care for newspapers including The Cincinnati Enquirer and Dayton Daily News. Her work has garnered several awards from the Associated Press, Cleveland Press Club and Society of Professional Journalists. She is based in Cincinnati, Ohio.


Marijuana firm Curaleaf makes stock trading debut in Canada with $4B valuation

Massachusetts-based Curaleaf made its trading debut on the Canadian Securities Exchange on Monday after a $400 million private placement. The multistate cannabis firm raised almost three times its initial offering target of $150 million, giving the company a valuation of $4 billion. Curaleaf, which changed its name in August from PalliaTech, is listed on the […]

Read More

Marijuana company 4Front completes $31 million raise to fund acquisitions, expansion

Multistate cannabis operator 4Front Holdings, which plans to go public in Canada, raised $31 million in a private placement of equity securities – more than double the initial offering of $15 million, according to a news release from the company. Phoenix-based 4Front plans to use the proceeds to invest in “top-tier talent,” acquisitions and the […]

Read More

Marijuana vape firm Pax Labs raises $20M but seeks to avoid VC dependence

San Francisco-based Pax Labs has closed a $20 million funding round, Bloomberg reported. CEO Bharat Vasan told the news outlet that the company wanted to keep the investment small to “avoid becoming overly dependent on venture capital.” Launched by the founders of e-cigarette maker Juul, Pax Labs vaporizers allow users to control the device with […]

Read More

Canadian acquisition company to purchase five US cannabis firms

Toronto-based Cannabis Strategies Acquisition Corp. (CSAC) has inked a deal to acquire five U.S. cannabis firms, with plans to combine the operations. CSAC – a special purpose acquisition company that is listed in Canada (CSA/A:CN) – will pay a total of 99 million Canadian dollars ($76 million) in cash for the five companies, with plans to […]

Read More

Canadian marijuana producer Aphria aims to list on the New York Stock Exchange

Aphria, one of Canada’s largest cannabis producers, has filed documents with U.S. securities regulators signaling its intent to list its shares on the New York Stock Exchange. If approved, the Ontario-based company will join a growing list of Canadian cannabis firms turning to the top U.S. exchanges to tap the globe’s largest pool of institutional […]

Read More

US cannabis firm places Wall Street Journal ad to appeal to Trump

Readers of the Wall Street Journal were greeted Tuesday morning by a full-page advertisement calling on President Donald Trump to lift federal marijuana bans, as U.S. cannabis firms seek to capitalize on Canada’s recreational launch. “We want to get cannabis into the national narrative because this industry presents the biggest economic opportunity our generation will […]

Read More

Ahead of Canada’s big day, forecast for cannabis industry gets a boost

On the eve of Canada’s historic launch of its recreational marijuana program, the global cannabis industry appears poised for explosive growth thanks to the confluence of a host of market developments. “The well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger (market) than we had originally forecast,” Wall Street analyst […]

Read More

Marijuana firm Cresco Labs charts plan to go public in Canada

Multistate cannabis operator Cresco Labs is looking to go public in Canada via a reverse takeover (RTO), the latest U.S. firm to use this path to a listing on the Canadian Securities Exchange (CSE). Cresco announced Wednesday that it’s pursuing an RTO of Randsburg International Gold, an Ontario-based firm that has no significant operations but is listed on […]

Read More

MedMen inks blockbuster $682 million stock deal to acquire medical cannabis firm PharmaCann

MedMen Enterprises has agreed to acquire multistate medical marijuana company PharmaCann in an all-stock deal valued at $682 million, inking what is believed to be the largest acquisition to date in the U.S. cannabis industry. The deal will double the number of states where Los Angeles-based MedMen has licenses to operate – expanding the firm’s […]

Read More